Skip to Main Content

Paper Details

Cost-effectiveness of ocriplasmin for the treatment of vitreomacular traction and macular hole.
J Mark Access Health Policy
7
2016
Author NameAffiliation
Ben van HoutUniversity of Sheffield
  • 1 - 1

Datasets

Release 1.2